drugset / Trial / NCT01927640

Dexmedetomidine for Reversal of Cocaine's Effects on the Heart

NCT01927640

RandomizedParallel-groupDouble-blindTreatment

Summary

This study will use myocardial contrast echocardiography performed during a continuous intravenous infusion of Definity microbubbles (Perflutren lipid microbubbles) to determine if dexmedetomidine (an intravenous central sympatholytic drug) can reverse all the cardiovascular effects of low-dose intranasal cocaine-including vasoconstriction in the coronary microcirculation-both in cocaine-naïve and non-treatment seeking cocaine-addicted subjects.

Timeline

Start
2013-02-01
Primary completion
2014-01-15
Completion
2014-01-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.3 ug/kg Intravenous
Subject Dexmedetomidine Other / unclassified 0.6 ug/kg Intravenous
Background Cocaine Small molecule 2 mg/kg Intranasal